This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology  • Skin Cancer  • Dermatology  • Dermatologic Disorders  • Hemangiomas  • Diagnosis  • Dermatologic Disorders, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Sadegh Amini, MD; Nancy H. Kim, MD; Deborah S. Zell, MD; Margaret C. Oliviero, ARNP; Harold S. Rabinovitz, MD
University of Miami Miller School of Medicine, Miami (Drs Amini, Kim, and Zell), and Skin and Cancer Associates, Plantation (Ms Oliviero and Dr Rabinovitz), Florida

Arch Dermatol. 2008;144(12):1671-1672.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Clinically, cutaneous lymphangioma circumscriptum (CLC) (Figure 1A and Figure 2A) should be differentiated from other vascular and lymphatic lesions, such as hemangiomas, angiokeratomas, lymphangioendotheliomas, and angiosarcomas,^1-3 as well as from warts, molluscum contagiosum, condyloma acuminata, and hidrocystoma.^4-7 The dermoscopic features of CLC demonstrate 2 distinct patterns⁸: (1) yellow lacunae surrounded by pale septa without inclusion of blood (Figure 1B) and (2) yellow to pink lacunae alternating with dark-red or bluish lacunae due to the inclusion of blood (Figure 2B). In pattern 2, the blood cells precipitate, giving rise to 2-tone lacunae. Histopathologically, pattern 1 is characterized by dilated dermal and/or subcutaneous lymphatic vessels, which are filled with lymphatic fluid (Figure 1C), while pattern 2 also includes variable concentrations of red blood . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?